本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AIM ImmunoTech Inc.

0.2136
-0.0093-4.17%
盤後0.21360.00000.00%19:32 EDT
成交量:191.35萬
成交額:40.96萬
市值:650.24萬
市盈率:-0.05
高:0.2250
開:0.2250
低:0.2120
收:0.2229
52周最高:2.98
52周最低:0.1901
股本:3,044.21萬
流通股本:3,027.92萬
量比:0.31
換手率:6.32%
股息:- -
股息率:- -
每股收益(TTM):-3.9303
每股收益(LYR):-30.8884
淨資產收益率:-2382.30%
總資產收益率:-82.58%
市淨率:0.84
市盈率(LYR):-0.01

資料載入中...

2024/11/16

SEC問詢函

Form CORRESP - Correspondence
2024/11/15

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/31

SEC問詢函

Form CORRESP - Correspondence
2024/10/01

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/11

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/03

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/07/30

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/20

SEC問詢函

Form CORRESP - Correspondence
2024/07/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/15

重要事件披露

Form 8-K - Current report
2024/07/12

SEC問詢函

Form CORRESP - Correspondence
2024/07/11

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/07/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans